Therapeutic pediatric apheresis

Journal of Clinical Apheresis

Volumn 15, Issue 1-2, 2000, Pages 129-157

  Kim, Haewon C ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; ARTICLE; BLOOD VOLUME; ERYTHROCYTE VOLUME; HUMAN; METHODOLOGY; PLASMAPHERESIS; TREATMENT INDICATION;

EID: 0034073652     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1101(2000)15:1/2<129::AID-JCA7>3.0.CO;2-H     Document Type: Article

References (87)

1. Kasprisin DO. Guidelines for performing therapeutic apheresis in children. Plasma Ther Transfus Technol 1984;5:213-218.
2. Kasprisin DO. Therapeutic apheresis in children. In: MacPherson JL, Kasprisin DO, editors. Therapeutic hemapheresis. Boca Raton: CRC Press, Inc.; 1985. p 73-89
3. Fosburg M. Therapeutic plasma exchange and cytapheresis. In: Nathan DG, Oski FA, editors. Hematology of infancy and childhood, 3rd edition. Philadelphia: W.B. Saunders Co.; 1987. p 1622-1631.
4. Kevy SV, Foshurg M. Therapeutic apheresis in childhood. J Clin Apheresis 1990;5:87-90.
5. Jeter EK, Rogers RL. Pediatric apheresis. In: McLeod BC, editor. Apheresis: principles and practice. Bethesda: AABB Press; 1997. p 409-421.
6. Gorlin JB. Therapeutic plasma exchange and cytapheresis. In: Nathan DG, Orkin SH, editors. "Hematology of infancy and childhood, 5th edition. Philadelphia: W.B. Saunders Co.; 1998. p 1827-1838.
7. Klein HG, editor. Clinical applications of therapeutic hemapheresis. J Clin Apheresis 1993;8:Special Issue.
8. Collins JA. Hemorrhage, shock, and burns. In: Petz LD, Swisher SN, editors. Clinical practice of blood transfusion. New York: Churchill Livingston, Inc.; 1981. p 425-453.
9. Hillman RS. Acute blood loss anemia . In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, editors. Williams hematology, 5th edition. New York: McGraw-Hill, Inc.; 1995. p 704-708.
10. Laks H, Pilon RN, Klovekorn P, Anderson W, MacCallum JR, O'Connor NE. Acute hemodilution: its effect on hemodynamics and oxygen transport in anesthetized man. Ann Surg 1974;180: 103-109.
11. Finch CA, Lenfant C. Oxygen transport in man. N Engl J Med 1972;286:407-415.
12. Spiess, BD, Sassetti R, McCarthy RJ, Narbone RF, Tuman KJ, Ivankovich AD. Autologous blood donation: hemodynamics in a high-risk patient population. Transfusion 1992;32:17-22.
13. Spahn DR, Smith LR, McRae RL, Leone BJ. Effects of acute isovolemic hemodilution and anesthesia on regional function in left ventricular myocardium with compromised coronary blood flow. Acta Anaesthesiol Scan 1992;36:628-636.
14. Spahn DR, Smith LR, Veronee CD, McRae RL, Hu W, Menius AJ, Lowe JE, Leone BJ. Acute isovolemic hemodilution and blood transfusion: effects on regional function and metabolism in myocardium with compromised coronary blood flow. J Thorac Cardiovasc Surg 1993;105:694-704.
15. Oski FA. The erythrocyte and its disorders. In: Nathan DG, Oski FA, editors. hematology of infancy and childhood, 4th edition. Philadelphia: W.B. Saunders Co.; 1993. p 28.
16. Clough L, Dugan N, Hulitt C, Farrell S, Parkin L, Larson P, Kim HC, Friedman DF. Improved method to estimate total blood volume for erythrocytapheresis using the Cobe Spectra in pediatric sickle cell disease patients. J Clin Apheresis 1998;13:81.
17. Nadler SB, Hidalgo JU, Bloct T. Prediction of blood volume in normal human adults. Surgery 1962;51:224.
18. Grishaber JE, Cunningham MC, Rohret PA, Strauss RG. Analysis of venous access for therapeutic plasma exchange in patients with neurological disease. J Clin Apheresis 1992;7:119-123.
19. Thompson L. Central venous catheters for apheresis access. J Clin Apheresis 1992;7:154-157.
20. Arnow PM, Quimosing EM, Brech M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993;16:778-784.
21. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;162:1598-1601.
22. Raad II, Luna M, Khalil SM, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994;271:1014-1016.
23. Krafte-Jacobs B, Sivit CJ, Mejia R, Pollack MM. Catheter-related thrombosis in critically ill children: Companion of catheters with and without heparin bonding. J Pediatr 1995;126:50-54.
24. Binford KL, McDonough EA, Jost PA, Nelson SC. Use of the Cathlink 20 port for erythrocytapheresis in pediatric patients with sickle cell disease. 25th Annual Meeting, National Sickle Cell Disease Program. Washington, D.C., September 15-20, 1997. p 210.
25. Mirro J Jr, Rao BN, Stokes DC, Austin BA, Kumar M, Dahl GV, Colten M, Balas L, Rafferty M, Hancock M, et al.. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 1989;7:214-222.
26. Abraham JL, Mullen JL. A prospective study of prolonged central venous access in leukemia. JAMA 1982;248:2868-2873.
27. Lee RB, Buckner M, Sharp KW. Do multi-lumen catheters increase central venous catheter sepsis compared to single-lumen catheters? J Trauma 1988;28:1472-1475.
28. Gil RT, Kruse JA, Thill-Beharozian MC, Carlson RW. Triple-vs single-lumen central venous catheters: a prospective study in a critically ill population. Arch Intern Med 1989;149:1139-1143.
29. Collignon P, Soni N, Pearson I, Sorell T, Woods P. Sepsis associated with central vein catheters in critically ill patients. Intens Care Med 1988;14:227-231.
30. Richet H, Hubert B, Nitemberg G, Andrenont A, Buu-Hot A, Ourbak P, Galicier C, Veron M, Boisivon A, Bouvier AM. Prospective multicenter study of vascular catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clinn Microbiol 1990;28:2520-2525.
31. Perkin RM, Levin DL. Shock in the pediatric patient, part I. J Pediatr 1982;101:163-169.
32. Meyer D, Bolgiano DC, Sayers M, Price T, Benson D, Slichter SJ. Red cell collection by apheresis technology. Transfusion 1993;33: 819-824.
33. Matthes G, Tofote U, Krause KP, Pawlow I, Kucera W, Lerche D. Improved red cell quality after erythroplasmapheresis with MCS-3P. J Clinn Apheresis 1994;9:183-188.
34. Brüggemann U, Roux EC, Hannig J, Nicolau C. Low-oxygen-affinity red cells produced in a large-volume, continuous-flow electroporation system. Transfusion 1995;35:478-486.
35. Kaboth U, Rumpf KW, Lipp T, Bigge J, Nauck M, Beyer JH, Seyde W, Kaboth W. Treatment of polycythemia vera by large volume erythrocytapheresis. Klin Wochenschr 1990;68:18-25.
36. Chong LL. Erythrocytapheresis using the Haemonetics Model 30 to permit surgical correction in an adult Tetralogy of Fallot. Plasma Ther Transfus Technol 1987;8:37-40.
37. Conte D, Mandelli C, Cesana M, Ferrini R, Marconi M, Bianchi A. Effectiveness of erythrocytapheresis in idiopathic hemochromatosis: report of 14 cases. The Int J Art Organs 1989;12:59-62.
38. Cesana M, Mandelli C, Tiribelli C, Bianchi PA, Conte D. Concomitant primary hemochromatosis and β-thalassemia trait: iron depletion by erythrocytapheresis and desferrioxamine. Am J Gastroenterol 1989;84:150-152.
39. Berdoukas VA, Kwan YL, Sansotta ML. A study on the value of red cell exchange transfusion in transfusion dependent anaemias. Clin Lab Haemat 1986;8:209-220.
40. Cohen AR, Friedman DF, Larson PJ, Horiuchi K, Manno CS, Kim HC. Erythrocyatpheresis to reduce iron loading in thalassemia. 40th Annual Meeting, The American Society of Hematology, Miami, FL, December 4-8, 1998.
41. Francina A, Chassard D, Baklouti F, George M, Estanove S. Open heart surgery in a patient with a high oxygen affinity haemoglobin variant. Anesthesia 1989;44:31-33.
42. Larson PJ, Friedman D, Reilly MP, Kattamis AC, Asakura T, Fortina P, Cohen AR, Kim HC, Manno CS. The presurgical management of a patient with a high oxygen affinity, unstable hemoglobin variant (Hb Bryn Mawr) with erythrocytapheresis. Transfusion 1997;37:703-707.
43. Werch J, Todd C. Resolution by erythroctapheresis of the exposure of an Rh-negative person to Rh-positive cells: an alternative treatment. Transfusion 1993;33:530-532.
44. Phillips P, Nantel S, Benny WB. Exchange transfusion as an adjunct to the treatment of severe falciparum malaria: Case report and review. Rev Infect Dis 1990;12:1100-1108.
45. Looareesuwan S, Phillips RE, Karbwang J, White NJ, Flegg PJ, Warrell DA. Plasmodium falciparum hyperparasitaemia: Use of exchange transfusion in seven patients and a review of the literature. Q J Med 1990;75:471-481.
46. Lercari G, Paganini G, Malfanti L, Rolla D, Machi AM, Rizzo F, Cannella G, Valbonesi M. Apheresis for severe malaria complicated by cerebral malaria, acute respiratory distress syndrome, acute renal failure and disseminated intravascular coagulation. J Clin Apheresis 1992;7:93-96.
47. Machtinger L, Telford III SR, Inducil C, Klapper E, Pepkowitz SH, Goldfinger D. Treatment of babesiosis by red blood cell exchange in an HIV-positive, splenectomized patient. J Clin Apheresis 1993;8:78-81.
48. Evenson DA, Perry E, Kloster B, Hurley R, Stroncek DF. Therapeutic apheresis for babesiosis. J Clin Apheresis 1998;13:32-36.
49. Golden PJ, Weinstein R. Treatment of high-risk, refractory acquired methemoglobinemia with automated red blood cell exchange. J Clin Apheresis 1998;13:28-31.
50. Jan KM, Usami S, Smith JA. Effects of transfusion on rheological properties of blood in sickle cell anemia. Transfusion 1982;22: 17-20.
51. Schmalzer EZ, Lee JO, Brown AK, Usami S, Chien S. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels: Implications for transfusion. Transfusion 1987;27:228-233.
52. Cohen AR, Martin MB, Silber JH, Kim HC, Ohene-Frempong K, Schwanz E. A modified transfusion program for prevention of stroke in sickle cell disease. Blood 1992;79:1657-1661.
53. Kim HC, Dugan NP, Silber JH, Martin MB, Schwartz E, Ohene-Frempong K, Cohen AR. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood 1994;83:1136-1142.
54. Adams DM, Schultz WH, Ware RE, Kinney TR. Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients. J Pediatr Hematol Oncol 1996;18:46-50.
55. Miller ST, Jensen D, Rao SP. Less intensive long-term transfusion therapy for sickle cell anemia and cerebrovascular accident. J Pediatr 1992;120:54-57.
56. Royal JE, Seeler RA. Hypertension, convulsions, and cerebral hemorrhage in sickle-cell anaemia patients after blood transfusion. Lancet 1978;2:1207.
57. Warth JA. Hypertension and a seizure following transfusion in an adult with sickle cell anemia. Arch Intern Med 1984;144:607-608.
58. Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, Gottschall, JL, Ash RC, Van Tuinen P, Horowitz MM, Flomenberg N. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood 1993;82:2310-2318.
59. Porter DL, Roth MS, McGarigle C, Ferrara JLM, Antin JH. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 1994;330:100-106.
60. Collins Jr RH, Pineiro LA, Nemunaitis JJ, Jain VK, Waxman D, Miller WV, Fay JW. Transfusion of donor buffy coal cells in the treatment of persistent or recurrent malignancy after allogeneic bone marrow transplantation. Transfusion 1995;35:891-898.
61. Lasky LC, Fox SB, Smith J, Bostrom B. Collection and use of peripheral blood stem cells in very small children. Bone Marrow Transplant 1991;7:281-284.
62. Takaue Y, Watanabe T, Abe T, Okamoto Y, Saito S, Shimizu T, Sato J, Hirao A, Suzue T, Koyama T, Kawano Y, Ninomiya T, Shimokawa T, Yokobayashi A, Takehara H, Kuroda Y. Experience with peripheral blood stem cell collection for autografts in children with active cancer. Bone Marrow Transplant 1992;10: 241-248.
63. Deméocq F, Kanold J, Chassagne J, Bezou MJ, Lutz P, deLumley L, Philip I, Vannier JP, Margueritte G, Lamagnére JP, Baranzelli MC, Lenat A, Carla H, Malpuech G. Successful blood stem cell collection and transplant in children weighing less than 25 kg. Bone Marrow Transplant 1994;13:43-50.
64. Gorlin JB, Humphreys D, Kent P, Galacki D, Kevy SV, Grupp S, Diller L, Weinstein H, Grier H, Shamberger R. Pediatric large volume peripheral blood progenitor cell collections from patients under 25 kg: A primer. J Clinn Apheresis 1996;11:195-203.
65. Prather K, Smith M, Bui K, Dickson L, Gerace M, McHugh M, Brunkow D, Pedersen K, Rowley S. Overview of pediatric peripheral blood stem cell harvests at Fred Hutchinson Cancer Research Center. J Clin Apheresis 1997;12:33.
66. Ventura GJ, Hester JP, Smith TL, Keating MJ. Acute myeloblastic leukemia with hyperleukocytosis: Risk factors for early mortality in induction. Am J Hematol 1998;27:34-37.
67. Maurer HS, Steinharz, Gaynon PS, Finkelstein JZ, Sather HN, Reaman GH, Bleyer WA, Hammond GD. The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia. J Clinn Oncol 1988;6:1425-1432.
68. Sleeper T, Smith J, McCullough J. Therapeutic cytapheresis using the Fenwal CS 3000 blood cell separator. Vox Sang 1985;48:193-200.
69. Vallejos CS, McCredie KB, Brittin GM, Freireich EJ. Biological effects of repeated leukapheresis of patients with chronic myelogenous leukemia. Blood 1973;42:925-933.
70. Curtis JE, Hersh EM, Freireich EJ. Leukapheresis therapy of chronic lymphocytic leukemia. Blood 1972;39:163-175.
71. Leibundgut K, von Rohr A, Brülhart K, Hirt A, Ischi E, Jeanneret C, Muff J, Ridolfi-Lüthy A, Wagner HP, Tobler A. The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in children. Bone Marrow Transplant 1995;15:25-31.
72. Bensinger W, Singer J, Appelbaum F, Lilleby K, Longin K, Rowley S, Clark E, Cliff R, Hansen J, Shields T, et al.. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993;81:3158-3163.
73. Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, Arbus M, Woolley PV, Chiazze L, Schein PS, Neefe JR. Cancer-associated hemolytic-uremic syndrome: Analysis of 85 cases from a national registry. J Clinn Oncol 1989;7:781-789.
74. Palmer A, Cairns T, Dische F, Gluck G, Gjorstrup P, Parsons V, Welsh K, Taube D. Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide. Nephrol Dial Transplant 1991;6:536-542.
75. Snyder Jr. HW, Cochran SK, Balint Jr. JP, Bertram JH, Mittelman A, Guthrie Jr. TH, Jones FR. Experience with protein A-Immunoadsorption in treatment-resistant adult immune thrombo-cytopenic purpura. Blood 1992;79:2237-2245.
76. Drew MJ. Resolution of refractory, classic thrombotic thrombo-cytopenic purpura after staphylococcal protein A immunoadsorption. Transfusion 1994;34:536-538.
77. Olivari MT, May CB, Johnson NA, Ring WS, Stephens MK. Treatment of acute vascular rejection with immunoadsorption. Circulation 1994;90: II-70-II-73.
78. Bosch T. Current status in extracorporeal immunomodulation: Immune disorders. Artificial Organs 1996;20:902-905.
79. Bennetts G, Woodbury C, Campbell C, et al. Use of the protein A (PROSORBA) column in children with chronic immune thrombocytopenic purpura. 5th International Congress of the World Apheresis Association. 1994. p 15.
80. Kim HC, Dugan NP, Snyder HW, et al. Protein A-immunoadsorption treatment in children with refractoriness to platelet transfusion (RPT). Blood 1992;80:222a.
81. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault De Ligny B, Niaudet P, Charpentier B, Soulillou JP. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994;330:7-14.
82. Kim HC, Norris C, Friedman DF, Larson PJ, Hulitt C, Dugan N, Clough L, Manno CS. Successful management of chronic refractory Evan's Syndrome with protein A immunoadsorption therapy. J Clin Apheresis 1996;11:107.
83. Garley DC, Hagen G, Chopek M. Increased frequency of pulmonary reactions with the use of Staph protein A column. J Clin Apheresis 1989;5:39.
84. Morrison FS, Huestis DW. Toxicity of the staphylococcal protein A immunoadsorption column. J Clin Apheresis 1992;7:171-172.
85. Huestis DW, Rifkin RM, Durie BGM, Sibley WA, Irani M. An unexpected complication following immunoadsorption with a staphylococcal protein A column. J Clin Apheresis 1992;7:75-77.
86. Smith RE, Gottschall JL, Pisciotta AV. Life-threatening reaction to staphylococcal protein A immunomodulation. J Clin Apheresis 1992;7:4-5.
87. Owen HG, Brecher ME. Atypical reactions associated with use of angiotensin- converting enzyme inhibitors and apheresis. Transfusion 1994;34:891-894.